DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Balaji Phosphates Limited — Issue of Securities

NSE 1 hr ago·18 Sept 2026, 1:38 pm

Balaji Phosphates

Balaji Phosphates Limited has informed the stock exchanges about the proposed issuance of additional securities. This announcement signals that the company is planning to raise fresh capital, likely through a rights issue, bonus issue, or a private placement of shares.

For investors, this development is significant as it indicates the company's intent to strengthen its financial position or fund expansion plans. The dilution of existing shareholder equity is a key factor to consider when evaluating the impact on the stock.

Investors should watch for the specific details of the issue, including the price, size, and purpose of the fund raising. This information will help determine whether the move is a strategic growth step or a necessary capital requirement.